Literature DB >> 24117646

Causes and treatments of achalasia, and primary disorders of the esophageal body.

Valter Nilton Felix1, Kenneth DeVault2, Roberto Penagini3, Alessandra Elvevi3, Lee Swanstrom4, Eelco Wassenaar5, Oscar M Crespin5, Carlos A Pellegrini5, Roy Wong6.   

Abstract

The following on achalasia and disorders of the esophageal body includes commentaries on controversies regarding whether patients with complete lower esophageal sphincter (LES) relaxation can be considered to exhibit early achalasia; the roles of different mucle components of the LES in achalasia; sensory neural pathways impaired in achalasia; indications for peroral endoscopic myotomy and advantages of the technique over laparoscopic and thorascopic myotomy; factors contributing to the success of surgical therapy for achalasia; modifications to the classification of esophageal body primary motility disorders in the advent of high-resolution manometry (HRM); analysis of the LES in differentiating between achalasia and diffuse esophageal spasm (DES); and appropriate treatment for DES, nutcracker esophagus (NE), and hypertensive LES (HTLES).
© 2013 New York Academy of Sciences.

Entities:  

Keywords:  GERD; achalasia; esophogastric junction; nutcracker esophagus; relaxation; swallowing

Mesh:

Year:  2013        PMID: 24117646     DOI: 10.1111/nyas.12254

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

Review 1.  Peroral endoscopic myotomy: an evolving treatment for achalasia.

Authors:  Robert Bechara; Haruo Ikeda; Haruhiro Inoue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-02       Impact factor: 46.802

2.  Electrical lower esophageal sphincter augmentation in patients with GERD and severe ineffective esophageal motility-a safety and efficacy study.

Authors:  Matthias Paireder; Ivan Kristo; Reza Asari; Gerd Jomrich; Johanns Steindl; Erwin Rieder; Sebastian F Schoppmann
Journal:  Surg Endosc       Date:  2019-01-22       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.